| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.79▲ | 1.79▲ | 1.79▲ | 1.76▼ | 1.82▼ |
| MA10 | 1.81▼ | 1.81▼ | 1.81▼ | 1.80▼ | 2.02▼ |
| MA20 | 1.83▼ | 1.87▼ | 1.87▼ | 1.83▼ | 2.02▼ |
| MA50 | 2.01▼ | 2.07▼ | 2.07▼ | 2.04▼ | 2.01▼ |
| MA100 | 2.06▼ | 2.04▼ | 2.03▼ | 2.02▼ | 2.28▼ |
| MA200 | 2.12▼ | 2.11▼ | 2.04▼ | 1.96▼ | 2.83▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | 0.002▲ | 0.001▲ | 0.000▲ | -0.038▼ |
| RSI | 38.382▼ | 38.138▼ | 38.614▼ | 37.930▼ | 42.232▼ |
| STOCH | 17.265▼ | 19.829▼ | 19.829▼ | 30.597 | 16.570▼ |
| WILL %R | -73.333 | -73.333 | -73.333 | -80.400▼ | -93.993▼ |
| CCI | -39.186 | -42.140 | -42.140 | -95.613 | -108.134▼ |
|
Wednesday, May 21, 2025 05:00 PM
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) announced the voting results of its shareholders at the Annual General Meeting (“AGM”), which took ...
|
|
Friday, March 21, 2025 07:10 AM
Topline Summary and Update. I've been on record a few times now as a tentative optimist for the investment thesis of Innate Pharma (NASDAQ:IPHA)(OTCPK:IPHYF), a biotech focused on a multipronged ...
|
|
Friday, October 04, 2024 01:45 PM
About This EventInnate Pharma (Nasdaq: IPHA), a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/07/25 | 1.75 | 1.81 | 1.7001 | 1.7432 | 4,886 |
| 10/07/25 | 1.71 | 1.81 | 1.71 | 1.81 | 12,591 |
| 09/07/25 | 1.75 | 1.75 | 1.72 | 1.72 | 7,208 |
| 08/07/25 | 1.775 | 1.8046 | 1.75 | 1.75 | 5,241 |
| 07/07/25 | 1.795 | 1.81 | 1.78 | 1.79 | 5,539 |
| 03/07/25 | 1.82 | 1.82 | 1.82 | 1.82 | 489 |
| 02/07/25 | 1.85 | 1.8989 | 1.82 | 1.82 | 5,448 |
| 01/07/25 | 1.7701 | 1.845 | 1.7701 | 1.845 | 5,454 |
| 30/06/25 | 1.81 | 1.85 | 1.71 | 1.815 | 14,261 |
| 27/06/25 | 1.88 | 1.92 | 1.82 | 1.85 | 3,484 |
|
|
||||
|
|
||||
|
|